Status:
UNKNOWN
Inter-observer Variability in the Segmentation of Prostate Tumour Lesions Using Multiparametric MRI (VARIOP)
Lead Sponsor:
University Hospital, Brest
Conditions:
Prostate Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Following the major technological and scientific advances in external radiotherapy in recent decades, thanks to the use of three-dimensional conformal techniques combined with intensity modulation, im...
Detailed Description
Following the major technological and scientific advances in external radiotherapy in recent decades, thanks to the use of three-dimensional conformal techniques combined with intensity modulation, im...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Histologically proven localized prostatic neoplasia on trans-rectal biopsies.
- Multiparametric prostate MRI performed prior to prostate biopsies.
- No opposition expressed
- Patient affiliated to a social security scheme
Exclusion
- History of surgery, prostatic irradiation or hormonal treatment prior to diagnosis.
- History of prostate cancer
- No identifiable target lesion on mpMRI (\<PIRADS 3)
- Opposition formulated
- Patient under legal protection (guardianship, curatorship, etc.)
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05996289
Start Date
August 1 2023
End Date
July 1 2024
Last Update
August 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Brest
Brest, France, 29609